Home Pharma Franchise How Can New Entrepreneurs Enter India’s Growing Ophthalmic Pharma Market?
India’s eye-care market is expanding at a twofold rate, with the shortage of reliable ophthalmic brands in suburban yet high-demand regions creating opportunities for PCD franchisees.
With an ageing population, increased diabetes, and more screen time, ophthalmic products are in greater demand. Starting up in this growing market can be made easy for new entrepreneurs. By choosing to start in this market using the PCD model, it poses less risk and you have to find a reliable Ophthalmic PCD Franchise Company in India. This blog covers how to start up in the growing ophthalmic pharma industry in India, including knowing market trends, creating a good product range and finding the right suppliers.
Vee Remedies is an Ophthalmic PCD Franchise Company in India, serving since 2007. It holds ISO certification. It offers high-demand ophthalmic product categories. It offers its franchise partners exclusive distribution rights along with marketing support.
Table of Contents
ToggleIndian Opthalmic Pharma market is estimated to be valued at USD 500 million to 1 billion in 2026. The Ophthalmic Pharma Market has added various products to its portfolio. The top one would be Retinal & Anti-VEGF therapies, holding 30-35% of market share. The top demanding regions for these products are Kerala, Tamil Nadu, Punjab, West Bengal etc . Next, with 21-28% of market share, are anti-glaucoma medications with high demand from Kerala, West Bengal, Maharashtra, and Punjab.
Lubricants & Dry eye drops hold 18-22% of the total market share. Corporate workers spend excessive time on screens, which reduces blink rate. Demand for these drops comes from Delhi NCR, Bengaluru, Mumbai, Pune, Chennai, etc. Next in the list are post-operative products helpful for reducing eye inflammation or pain associated with surgeries. These products hold 15-20% of the market share, with demand coming from Tamil Nadu, Gujarat, Uttar Pradesh and Karnataka.
To enter the Ophthalmic Pharma Market, you would need the support of an Ophthalmic PCD Franchise Company in India who guide you throughout your journey.
Months 1-2: Choose territory, confirm 3-4 supply partners, Licences and GST
Months 2-4: Sign contract, order opening stock, get 4-6 key products on sale, begin visiting key opinion leaders in
ophthalmology.
Months 4-12: Monitor recurring orders, build relationships with local chemists and Optical chains, manage expiry.
Year 2+: Expand to surrounding areas and introduce trusted products by doctors
An ophthalmic product portfolio should be a mix of frequently prescribed products, complementary therapies, and a few specialised products. There’s no use of adding on similar products serving no different purpose:
Dry Eye & Lubricants: To address different dry-eye issues, consider adding lubricants such as CMC, Sodium hyaluronate, PEG + propylene, and mainly gel-based lubricants.
Anti-allergic products: To combat eye issues such as itching, redness, and swelling, it is a good idea to add olopatadine-, bepotastine-, and alcaftadine-based eye drops to your portfolio.
Glaucoma products: Glaucoma products help reduce the pressure inside the eyes and these are often a part of long-term treatment. For IOP management, you can consider adding products such as timolol, brimonidine, dorzolamide and combination therapies.
Post-operative formulations: Nepafenac, bromfenac and ketorolac are the eye drops recommended post eye operations such as cataract. They help reduce the pain and inflammation associated with the same.
Eye drops are sterile products, so one bad batch can damage your credibility with doctors. Your supplier decides your reputation, so check these five things before you sign.
Vee Remedies is a leading pharmaceutical company that was established in 2007. It is an ISO certified ophthalmic PCD Franchise company in India. It offers more than 600 products for PCD franchise opportunities.
Conclusion
Vee Remedies is a prominent Ophthalmic PCD Franchise Company in India. It has been equipped well to help to enter the growing Ophthalmic Pharma market with ease. It follows a flexible Minimum order quantity policy and does not charge any extra registration fees when an investor gets registered with it for a PCD Pharma Franchise company. It offers PAN-India distribution services.